Managing work participation for people with rheumatic and musculoskeletal diseases

Wilkie, Ross; Björk, Mathilda; Costa-Black, Kátia M.; Parker, Marty; Pransky, Glenn

doi:10.1016/j.berh.2020.101517

Cited by 19 publications

(28 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Health-related quality of life is closely related to pain severity, and pain interference is strongly associated with work disability and premature work loss 34 , 35 . However, supportive workplaces can improve return to work, sickness absence, and presenteeism outcomes for people with chronic conditions 32 , 36 . This is consistent with the findings of this study: models that included osteoarthritis and occupation type suggested that, by age 60, people with osteoarthritis who are self-employed achieve similar HWLE outcomes as people without osteoarthritis in non-manual or manual occupations.…”

Section: Discussionmentioning

confidence: 99%

Healthy working life expectancy at age 50 for people with and without osteoarthritis in local and national English populations

Lynch

Bucknall

Jagger

et al. 2022

Sci Rep

Self Cite

View full text Add to dashboard Cite

Retirement ages are rising in many countries to offset the challenges of population ageing, but osteoarthritis is an age-associated disease that is becoming more prevalent and may limit capacity to work until older ages. We aimed to assess the impact of osteoarthritis on healthy working life expectancy (HWLE) by comparing HWLE for people with and without osteoarthritis from ages 50 and 65 nationally and in a local area in England. Mortality-linked data for adults aged ≥ 50 years were used from six waves (2002–13) of the English Longitudinal Study of Ageing and from three time points of the North Staffordshire Osteoarthritis Project. HWLE was defined as the average number of years expected to be spent healthy (no limiting long-standing illness) and in paid work (employment or self-employment), and was estimated for people with and without osteoarthritis and by sex and occupation type using interpolated Markov chain multi-state modelling. HWLE from age 50 years was a third lower for people with osteoarthritis compared to people without osteoarthritis both nationally (5.68 95% CI [5.29, 6.07] years compared to 10.00 [9.74, 10.26]) and in North Staffordshire (4.31 [3.68, 4.94] years compared to 6.90 [6.57, 7.24]). HWLE from age 65 years for self-employed people with osteoarthritis exceeded HWLE for people without osteoarthritis in manual or non-manual occupations. Osteoarthritis was associated with a significantly shorter HWLE. People with osteoarthritis are likely to have significantly impaired working ability and capacity to work until older ages, especially in regions with poorer health and work outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Healthy working life expectancy at age 50 for people with and without osteoarthritis in local and national English populations

Lynch

Bucknall

Jagger

et al. 2022

Sci Rep

Self Cite

View full text Add to dashboard Cite

show abstract

“…In The Netherlands, many patients with rheumatic diseases may work part time, 20 and those with more severe disease may have left the labor force earlier, which may have resulted in a selection of relatively healthier workers. 30,31 This healthy worker effect is confirmed by the low prevalence of rheumatic diseases and CVDs at baseline in our cohort. In The Netherlands, just before assembling our cohort, people with chronic diseases were able to qualify for a disability pension relatively easily, and it is likely that these individuals had already left the labor force.…”

Section: Discussionsupporting

confidence: 73%

“…ischemic heart disease, stroke), mainly through inflammation enhanced atherosclerotic plaque formation. [29][30][31] With regard to work participation, premature cardiovascular mortality may contribute to reduced work participation in people of working-age with RMDs and this contribution may have been underestimated. 32 Management of this cardiovascular risk, including more strict prevention of cardiovascular disease in the employed population additional to optimal control of disease activity, seems an interesting and essential approach to reduce the effects on health-related quality of life and adverse work outcomes in people suffering from those chronic inflammatory RMDs.…”

Section: Cardiovascular Co-morbidities and Work Participationmentioning

confidence: 99%

“…Early interventions to prevent long-term adverse work outcomes are essential, because having work is associated with higher levels of a persons' health and wellbeing, and a reduced burden of disease on societal expenditures. [29][30][31] This can be achieved by more intensive treatment strategies of the underlying disease to reduce disease activity and improve work outcomes. 32 Another intervention is early detection of risk factors for adverse work outcomes, amongst other options not presented in this thesis.…”

Section: Prevention Of Adverse Work Outcomesmentioning

confidence: 99%

“…In addition, there remains a substantial gap between axial SpA patients and the general population in terms of work participation, suggesting that pharmacological interventions alone are not enough and other (multidisciplinary) approaches are needed. 31 In Chapter 5 we presented the results of the development and validation of a multivariable risk prediction model, discriminating between workers with high-and low-risk for longterm sickness absence in the coming year. We used data from 11,221 working persons in the STREAM cohort to develop this multivariable risk prediction model for long-term sickness absence lasting ≥28 accumulated working days in the coming year.…”

Section: Prevention Of Adverse Work Outcomesmentioning

confidence: 99%

See 2 more Smart Citations

Work participation and health in rheumatic and musculoskeletal diseases

Burg

Lennart²

View full text Add to dashboard Cite

People interested in the research are advised to contact the author for the final version of the publication, or visit the DOI to the publisher's website.• The final author version and the galley proof are versions of the publication after peer review.• The final published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User Agreement:

show abstract

Benchmarking community/primary care musculoskeletal services: A narrative review and recommendation

Burgess

Lewis

Hill

2022

Musculoskeletal Care

View full text Add to dashboard Cite

Introduction: High quality data on service performance is essential in healthcare to evidence efficacy, efficiency, and value. There remains a paucity of publicly reported data in community and primary care musculoskeletal (MSK) services. There is also a lack of guidance on which metrics MSK services should be collecting and reporting, and how this data could be used to directly improve patient outcomes, experiences, and value.Method: A narrative review of the evidence around benchmarking MSK services was undertaken with a focus on how to develop routine data collection within community/primary care settings, and how to develop benchmarking capabilities for the future, looking towards a national MSK audit. This evidence was triangulated with the findings from recent MSK data studies undertaken by the authors and emerging UK policy and guidance in this area. Recommendations:To enable MSK benchmarking services need to collect consistent, standardised outcomes and, therefore, we have developed a recommendation on a minimum MSK 'core outcome set' of Patient Reported Outcome Measures (PROMs) and Patient Reported Experience Measures (PREMs) (PROMs: MSK-HQ, NPRS, WPAI; PREMs: National MSK PREM). In addition, we make recommendations on the use of a standardised evidence-based method for case-mix adjustment and outlier identification (using the following baseline demographics and clinical factors; age, sex, ethnicity, pain site, comorbidities, duration of symptoms, previous surgery, previous pain episodes), alongside considerations on how this data should be integrated and reported within NHS systems. Conclusions:Capturing high quality MSK data in a standardised, consistent, and sustainable way is a significant challenge. Policy holders, commissioners, managers, and clinicians need to be realistic with expectations, and take time to explore barriers to implementation including, funding, digital infrastructure/intra-operability, data sharing/governance, digital literacy, and local/national leadership. Next steps include developing a national MSK audit programme to provide a benchmarking model to support continuous improvements in care quality for patients living with MSK conditions.

show abstract

Managing work participation for people with rheumatic and musculoskeletal diseases

Cited by 19 publications

References 45 publications

Healthy working life expectancy at age 50 for people with and without osteoarthritis in local and national English populations

Healthy working life expectancy at age 50 for people with and without osteoarthritis in local and national English populations

Work participation and health in rheumatic and musculoskeletal diseases

Benchmarking community/primary care musculoskeletal services: A narrative review and recommendation

Contact Info

Product

Resources

About